SUPRIYA Supriya Lifescience Ltd Earnings Reports Announcement 2024 - Q2 FY25 Results Supriya Lifescience Ltd reported a 19% year-on-year revenue increase to Rs. 166 crores for Q2 FY25, with an EBITDA margin of 39% and a PAT margin of 28%, affirming its operational excellence and strategic focus on expanding its product portfolio..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Supriya Lifescience Ltd